Friday 30 August 2019

Assisted Reproductive Technology (ART) Market size, Share, Analysis, Global Industry Demand By 2023

Assisted reproductive technology (ART) market is gaining precedence owing to its ability to cure women having infertility issues. The assisted reproductive technology industry includes fertility medication, in vitro fertilization and surrogacy. The global assisted reproductive technology market can experience a 10% CAGR during the forecast period (2018-2023), reveals Market Research Future (MRFR) in a report that covers drivers of the said market and segments in detail. Infertility cases are on the rise, that too, at an alarming rate. This has been triggered by a sedentary lifestyle, obesity, ovulation disorder, unhealthy diet, increasing intake of tobacco & alcohol, and chronic diseases.
Get Free Sample PDF Copy Of Global Assisted Reproductive Technology Market Research Report!!https://www.marketresearchfuture.com/sample_request/6359
Assisted reproductive technology includes fertility medication, in vitro fertilization, and other processes used to counter infertility in women and men and bring about fertilization. Causes of infertility among women may range from ovulation disorders and uterine or cervical abnormalities to cancer and endometriosis. Lifestyle factors such as excessive smoking and obesity also play a part in the causation of infertility. The rising prevalence of infertility conditions around the world is set to be the prime driver for the assisted reproductive technology market, as the prevalence of the lifestyle factors contributing to infertility has risen spectacularly over the last few decades.
On the other hand, the risks of assisted reproductive technology and the relatively low chances of success are likely to count against the assisted reproductive technology market over the forecast period. Assisted reproductive treatments are highly expensive, eliminating a large share of the population from availing them, particularly in developing countries. They also carry a risk of premature births and low birth weight in the newborns. The underlying factors responsible for the infertility may also have an effect on the assisted pregnancy, leading to birth defects in the child. Such factors are likely to hold back the assisted reproductive technology market over the forecast period.
Assisted Reproductive Technology Market- Competitive Analysis:
Leading players in the global assisted reproductive technology market include Cosmos Biomedical Limited, Bloom IVF Centre, Parallabs, Anecova, Microm Ltd., Cooper Surgical Inc., European Sperm Bank, Hamilton Throne Ltd., Irvine Scientific, Ferring Pharmaceuticals, Merck KGaA, Origio, OvaScience, Cryolab Ltd., and California Cryobank.
Assisted Reproductive Technology Market- Segmentation:
The global assisted reproductive technology market is segmented by diagnosis, type, end user, and region.
By Diagnosis, the global assisted reproductive technology market is segmented into ovulation testing and hysterosalpingography.
By Type, the assisted reproductive technology market is segmented into ovulation induction, artificial insemination, and surrogacy.
By End-Use, the assisted reproductive technology market is segmented into hospitals & clinics and IVF centers.
Assisted Reproductive Technology Market- Regional Analysis:
On the basis of region, the global assisted reproductive technology market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.
Europe is expected to remain the leading contributor to the global assisted reproductive technology market over the forecast period due to the relative economic freedom of new mothers in the region, which means they can avail a number of assisted reproductive technologies with ease. The increasing research and innovation in assisted reproductive technologies in Europe is also likely to be a major driver for the assisted reproductive technology market in Europe over the forecast period. The increasing access to infertility treatments in this region is likely to be a major driver for the assisted reproductive technology market in the region.
North America is likely to follow Europe in the global assisted reproductive technology market due to the growing prevalence of infertility in the region. Lifestyle factors contributing to infertility, such as obesity, drinking, and smoking, are highly prevalent among North American men and women, especially in the U.S., leading to a steady growth in the rate of infertility. Obesity, in particular, is rampant among both men and women in North America, leading to a growing prevalence of infertility. This is likely to drive the assisted reproductive technology market in the Americas region over the forecast period.
Asia Pacific is also likely to be a key contributor to the global assisted reproductive technology market over the forecast period due to the growing awareness about fertility treatments. It is expected to emerge as the fastest growing regional market for assisted reproductive technologies over the forecast period.
TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
Continued...
LIST OF TABLES
Table 1 Assisted Reproductive Technology (ART) Market Industry Synopsis, 2018–2023
Table 2 Global Assisted Reproductive Technology (ART) Market Estimates & Forecast, 2018–2023, (USD Million)
Table 3 Global Assisted Reproductive Technology (ART) Market, By Region, 2018–2023, (USD Million)
Table 4 Global Assisted Reproductive Technology (ART) Market, By Diagnosis, 2018–2023, (USD Million)
Table 5 Global Assisted Reproductive Technology (ART) Market, By Type, 2018–2023, (USD Million)
Table 6 Global Assisted Reproductive Technology (ART) Market, By End-User, 2018–2023, (USD Million)
Table 7 North America Assisted Reproductive Technology (ART) Market, By Diagnosis, 2018–2023, (USD Million)
Table 8 North America Assisted Reproductive Technology (ART) Market, By Type, 2018–2023, (USD Million)
Table 9 North America Assisted Reproductive Technology (ART) Market, By End-User, 2018–2023, (USD Million)
Table 10 US Assisted Reproductive Technology (ART) Market, By Diagnosis, 2018–2023, (USD Million)
Get More Information on Assisted Reproductive Technology Market  Research Report- Global Forecast to 2023@https://www.marketresearchfuture.com/reports/assisted-reproductive-technology-market-6359
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , ,

Surgical Lights Market by Application, By Type, by End User and Region

Overview:
Market Research Future (MRFR) in their latest report on the surgical light market revealed a possibility of 4.53% CAGR during the forecast period (2014-2023). Surgical lights are also known as surgical lamps or operating light. These lights are used to assist surgeons during surgical procedures. An effective surgery depends much on proper illumination of the area to avoid any kind of injury to the patient. There are several factors that influence the quality of surgical lights Color Rendering Index (CRI), shadow dilution, brightness, Correlated Color Temperature (CCT), homogeneity, and others.
The major driving factor for the surgical light market is the increasing demand for latest technologies to provide patients best possible care. At the same time, doctors and his associates require maximum assistance to help them perform better. Hence, hospitals and other surgical service providers are installing the best quality products. This can ensure growth for the surgical lights market in the coming years.
Competitive Landscape:
Several players in the global surgical lights market are making substantial changes. They are Technomed India BihlerMED, A-dec Inc., Getinge AB, CV Medical, Hill-Rom Services Inc., Integra LifeSciences Corporation, Medical GmbH & Co. KG, KONINKLIJKE PHILIPS N.V., Herbert Waldmann GmbH & Co. KG, S.I.M.E.O.N. Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Stryker, SKYTRON, STERIS plc, Sunnex Group, and others. These companies get involved in strategic development to take the market forward.
In 2019, Surgiris introduced their surgical lights such as EPURE and DIASYS to the Arabian market to grab the opportunity of having their business expanded in the Middle East region. EPURE has LED control and technologies such as FOCUSMATIC and MOTION MATIC play important role in making it one of the best available in the market.  
Segmental Analysis:
MRFR’s attempt to dig deep into the surgical lights market is based on a segmentation by type, technology, application, and end-users.
Based on the type, the global surgical lights market includes surgical lights and examination lights. The surgical lights segment comprises mobile surgical headlights, surgical lights, ceiling mounted, and wall mounted surgical lights. The examination lights segment is sub-segmented into vein light, endoscopes lights, general exam light, and medical penlight.
By technology, the global surgical lights market is segmented into LED and halogen lights. The LED segment is gaining much prominence due to its durability.
By application, the surgical lights market comprises dental procedures, endoscopy procedures, surgical suites, and others.
Based on the end-user, the global surgical lights market consists hospital operating rooms, ambulatory surgical centers, and procedure rooms. The hospital operating rooms segment is getting much traction due to scope for investment and infrastructure.
Regional Analysis:
MRFR’s take on the global surgical light market includes regions, namely, the America, Europe, Asia Pacific, and the Middle East & Africa (MEA).
The market of the Americas includes a special focus on the LED surgical lights in operating rooms and ambulatory surgical centers. The regional market is primarily getting driven by North America where market giants like the U.S. and Canada are booming due to their superior infrastructure as that facilitates easy incorporation of any new technology. South America could also create substantial demand for the market owing to the betterment in healthcare structure.
Europe’s growth is mostly depending on the number of suppliers in the region. They are providing in the implementation of advanced technology inside the operation theatre. Germany, U.K, and France are contributing the most and it is due to their superior technological backup.
The APAC market is benefitting from the synergistic efforts shown by governments and private organizations. The growing intake of LED lights for a better infrastructural setup is expected to provide the market much-needed support. India, China, and Japan are the largest contributors. This regional growth is getting more thrust due to the burgeoning demand for cost-effective surgical lighting solutions.
In the Middle East & Africa, the market would get substantial traction from countries Saudi Arabia, Qatar, Oman, and Dubai. These regions are investing significantly to take the market forward.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , , , ,

Thursday 29 August 2019

Recent research: Cancer Registry Software Market growing at high CAGR by 2024: Size, Share, Analysis, Upcoming Trends

Cancer Registry Software Market Highlights
The global cancer registry software market held a market value of USD 56.4 million in 2019 and is projected to grow at a CAGR of 10.7% over the forecast period.  
Cancer registry software is a disease registry that is mainly used to establish and maintain a cancer incidence reporting system. It acts as an informational resource for the investigation of cancer and its causes. This type of registry software is important as cancer is among the leading causes of death worldwide and therefore the collection of data on cancer cases from diagnosis through survivorship is beneficial to help identify trends and ultimately improve care for patients that are fighting cancer.
However, privacy and data security-related concerns and reluctance to adopt advanced solutions may restrict the growth of the market during the forecast period.
Cancer Registry Software Market Key Players
Some of the prominent players in the global cancer registry software market are Onco, Inc., Rocky Mountain Cancer Data Systems, McKesson Corporation, Elekta AB (PUB), C/Net Solutions, Electronic Registry Systems, Inc., Rocky Mountain Cancer Data Systems, McKesson Corporation, Ordinal Data Inc, Conduent Inc, IBM, Himagine Solutions Inc.
Cancer Registry Software Market Regional Analysis
On a regional basis, the Americas is anticipated to dominate the global cancer registry software market owing to the innovative product development and increasing investment in research and development for innovation in the region.  
Europe is expected to hold the second largest position in the global cancer registry software market owing to the presence of strong academic & research base and availability of funding for research in the European countries.
Asia-Pacific is anticipated to be the fastest growing region in the global cancer registry software market owing to the shift of pharmaceutical companies to countries such as India and China, which are low-cost manufacturing regions.
The Middle East & Africa has the least share of the global cancer registry software market.  Moreover, the major market share of the region is expected to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.
Cancer Registry Software Market Segmentation
The global cancer registry software market has been segmented into type, deployment model, database type, functionality and end user.
By type, the market has been segmented into integrated software and standalone software.
Based on deployment model, the market has been segmented into cloud-based models and on-premise models.
On the basis of database type, the market has been segmented into commercial databases and public databases.
By functionality, the market has been segmented into patient care management, product outcome evaluation, cancer reporting to meet state and federal regulations, medical research & clinical studies.
The market, by end user, has been segmented into hospitals & medical practices, government organizations & research centers, pharmaceutical, biotechnology, and medical device companies, and others.
About Market Research Future: 
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , ,

Monday 26 August 2019

Anticholinergic Drugs Industry Size, Share, Global Trends, New Drugs Application, Demand And Forecast to 2023

Anticholinergic Drugs Market Report covers a valuable source of perceptive information for business strategists. Anticholinergic Drugs Industry provides the overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elegant description of the value chain and its distributor analysis.

Anticholinergic Drugs Market Highlights
The Global Anticholinergic Drugs Market is expected to register a CAGR of 4.50% during the forecast period with a market value of USD 7,149.90 million till 2024. Anticholinergics drugs are a broad class of drugs that block acetylcholine-mediated neurotransmission in the smooth muscle, heart, central, and peripheral nervous systems. Acetylcholine is a neurotransmitter, or a chemical messenger released by nerve cells to send signals to other cells.


The increasing prevalence of chronic diseases and increasing investments and funding in the field of life science research has led to the growth of the global anticholinergic drugs market in recent years. Moreover, the aging population is expected to fuel market growth. However, side-effects of anticholinergic drugs and stringent regulations are projected to hamper the growth of the market during the assessment period.

Anticholinergic Drugs Market Studied By Top Players
Market Research Future (MRFR) recognizes following companies as key players in the global anticholinergic drugs market that include Pfizer Inc. (US), Allergan Plc (US), Astellas Pharma Inc. (Japan), Johnson & Johnson Services Inc. (US), Teva Pharmaceutical Industries Ltd (Israel), Sanofi (France), GlaxoSmithKline Plc (UK), Boehringer Ingelheim International GmbH (Germany) and others.

Anticholinergic Drugs Market- Segment Analysis
The anticholinergic drugs market, based on product type, has been segmented into synthetic compounds, natural, semi-synthetic compounds. The anticholinergic drugs market, based on application, has been segmented into the overactive bladder, Parkinson’s disease, chronic obstructive pulmonary disease, muscle spasms, irritable bowel syndrome. On the basis of route of administration, the market is segmented into oral, parenteral, topical. On the basis of end user, the market is segmented into hospitals and pharmacies.

 Regional Analysis
The Global Anticholinergic Drugs Market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
The Americas is expected to hold the largest share of the global anticholinergic drugs market. This owes to the rising geriatric population along with the high prevalence of CNS diseases and demand for effective therapies. The Europe market demonstrated substantial growth in the market due to the rising prevalence of bladder overactivity, increasing geriatric population, and rising healthcare expenditure. Germany held a share of 25.8% in the Western Europe anticholinergic drugs market in 2018. Asia-Pacific is estimated to be the fastest growing region in the global market due to the presence of a large number of research organizations and development of new infrastructure to support the healthcare industry. Also, the Middle East and Africa region is expected to show the least growth owing to low per capita income and lack of adequate healthcare spending.
Key Findings of the Study
  • The Global Anticholinergic Drugs Market is projected to reach USD 7,149.90 Million by 2024 at a CAGR of 4.50% during the review period from 2019 to 2024.
  • Americas accounted for the largest share of the global market due to the high prevalence of CNS diseases and demand for effective therapies.
  • The overactive bladder application segment accounted for the largest market share of 4% in 2018.
 List Of Table
Table 1 List Of Assumptions 15 
Table 2 Global Anticholinergic Drugs Market, By Type 2016-2024 (Usd Million) 32 
Table 3 Global Anticholinergic Drugs Market For Synthetic Compounds, By Region, 2016–2024 (Usd Million) 32 
Table 4 Global Anticholinergic Drugs Market For Natural, By Region, 2016–2024 (Usd Million) 33 
Table 5 Global Anticholinergic Drugs Market For Semi-Synthetic Compounds, By Region, 2016–2024 (Usd Million) 33
Table 6 Global Anticholinergic Drugs Market, By Application 2016-2024 (Usd Million) 36 
Table 7 Global Anticholinergic Drugs Market For Overactive Bladder, By Region, 2016–2024 (Usd Million) 36 
Table 8 Global Anticholinergic Drugs Market For Parkinson’s Disease, By Region, 2016–2024 (Usd Million) 37 
Table 9 Global Anticholinergic Drugs Market For Chronic Obstructive Pulmonary Disease (Copd), By Region, 
2016–2024 (Usd Million) 37 
Table 10 Global Anticholinergic Drugs Market For Muscle Spasms, By Region, 2016–2024 (Usd Million) 38 

Trending Reports



 About Market Research Future: 
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , ,

Global Osteosarcoma Market (2017-2023) Growing at a CAGR of 6.40%

Osteosarcoma Market Highlights
Osteosarcoma is a bone tumor that may occur in any bone of the body. Approximately 75% of cases, patients with osteosarcoma are between 15-25 years old. Male are more as often suffer from osteosarcoma than females.
Currently, chemotherapy for osteosarcoma is usually directed within prospective clinical trials. In drug treatment, doxorubicin is the first and most commonly used the drug for osteosarcoma patients. Cisplatin is the second most commonly used drug and is included in most of the protocols. High-dose methotrexate with leucovorin is the third most commonly used drug. These treatment methods are likely to boost the pharmaceutical industries resulting in the growth of the osteosarcoma market.
The global osteosarcoma market is expected to grow at a CAGR of 6.40% during the forecast period 2017-2023.
Taste the market data and market information presented through more than 128 market data tables and figures spread over 134 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Osteosarcoma market research report–Global forecast till 2023.”


Major Players in the Osteosarcoma Market
Some of the key players in the global market are Pfizer (U.S.), Novartis (U.S.), Spectrum Pharmaceuticals, Inc. (U.S.), Hikma Pharmaceuticals (U.K), Baxter (U.S.), Advaxis Inc., Bellicum Pharmaceuticals (U.S.), and Inc. Isofol Medical AB (Sweden). 
Regional Analysis
The global osteosarcoma market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.
Constantly increasing the patient population of cancer, increasing the number of cases in children, and increasing government support for research in the healthcare domain drive the Americas market growth and remains responsible for making it one of the largest global market.
Europe holds the second position in the market due to increasing development and more focus on healthcare domain. Countries such as Germany and France are investing more in research & development to develop new treatment methods for various types of cancer. According to the European Cancer Organization, incidence rates of cancer diseases including osteosarcoma have increased by 41% and 50% respectively between 1993-1995 and 2012-2014. It is one of the major factors responsible for the growth of the market in this region.    
The Asia Pacific is expected to be the fastest growing region in the global osteosarcoma market owing to emerging player and focus of established players in this region. Moreover, developing countries such as India, China, and the Republic of Korea are focusing on research & development and minimizing barriers to drug approval, which is projected to boost the market growth in this region.
On the other hand, the Middle East & Africa owns the minimum market share of the osteosarcoma market due to less development in the healthcare services such as new and advanced diagnosis & treatment methods in healthcare domain.
Segmentation
The global osteosarcoma market is segmented on the basis of types, diagnosis, treatment, and end user.
On the basis of the types, it is further segmented into intramedullary osteosarcoma, juxtacortical osteosarcoma, and extra-skeletal osteosarcoma.
On the basis of the diagnosis, the market is segmented into biopsy, X-ray, MRI, CT Scan, bone scan, and others.
On the basis of the treatment, the market is segmented into chemotherapy, surgery, radiation therapy, and others.
On the basis of the end user, the market is segmented into hospitals & clinics, cancer research centers, and others.
Table Of Content 
Chapter 1. Report Prologue
 Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Osteosarcoma Market, By Type Of Service
To Be Continued... 

Browse Full Report with TOC @ 

Hottest Trending Reports



About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , ,

Thursday 22 August 2019

Pedicle Screw Systems Market Trends, Drivers, Strategies, Applications and Competitive Landscape 2023

Pedicle Screw Systems Market – Overview
Pedicle Screw Systems are used in spinal surgery in the lumbar spine for more complex anatomy such as the thoracic and thoracolumbar level. Over the past few years, the pedicle screw system market is growing rapidly due to the rising prevalence of arthritis and increasing incidence of spinal cord injuries. Moreover, the increasing R&D expenditures and aggressive strategies adopted by the top players such as new product launches are escalating the market on the global platform.
Acknowledging the exponential traction, the market perceives currently, Market Research Future (MRFR) in its recently published study report asserts that the global pedicle screw system market will reach USD 506.65 MN by 2023, registering approximately 6.3 % CAGR throughout the forecast period (2018–2023).
Additional factors helping the market to boost further, include the increasing number of geriatric populaces and growing preference of minimally invasive surgeries. Moreover, accident and trauma cases along with hyper-obesity disorders drive the demand for pedicle screw systems, causing severe spinal injuries.

FREE SAMPLE COPY OF “Pedicle Screw Systems Market Research Report – Global Forecast till 2023” @ https://www.marketresearchfuture.com/sample_request/7081

With the vast technological advancements that happened over the last decade, pedicle screw systems have undergone several bettering transformations, and with each innovation and bettering efforts, pedicle screw system market has garnered prominence & value, globally. Simultaneously, the increasing prevalence of conditions and disorders such as arthritis of the spine, scoliosis and other deformities of the spine has fostered the market growth. 
On the other hand, factors such as the high cost associated with pedicle screw systems, delayed processes of product approval and stringent regulatory frameworks are expected to impede the growth of the market during the assessment period.
Leading Key Players
Key players leading the global pedicle screw systems market include Amedica Corporation, Alphatec Spine, Inc., B. Braun Melsungen AG, Globus Medical, Inc., Depuy Synthes, K2M Group Holdings, Inc., Nvision Biomedical Technologies, LLC., Medtronic PLC, Orthofix International N.V., SeaSpine, RTI Surgical, Inc., Stryker Corporation, and Zimmer Biomet Holdings, Inc. among others.
Pedicle Screw Systems Market – Segments
For enhanced understanding, the market has been segmented into six key dynamics: -
By Surgery Type : Open Surgery and Minimally Invasive Surgery
By Product Type               : Polyaxial Pedicle Screw Systems and Monoaxial Pedicle Screw Systems among others.
By Indication                      : Spinal Degeneration, Spinal Trauma, and Spinal Deformities among others.
By Application                   : Thoracolumbar Fusion and Spinal Cervical Fusion among others.
By End-user                        :  Hospitals & Clinics and Research Organization & Academic Institute among others.
By Regions                          : North America, Asia Pacific, Europe, and the Rest-of-the-World.

Detailed Regional Analysis
The North American region, heading with the increasing number of populaces suffering from lumbar spine accounts for the leading market in the global pedicle screw systems. Countries like the U.S. and Canada, backed by substantial technological innovation and advancement in manufacturing processes, play a vital role in the growth of the regional market.
Factors such as the contribution of nanotechnology in the spinal care, rising prevalence of spinal disorders, increasing geriatric population, and the increase in FDA approvals, substantiate the growth of pedicle screws systems market in the region. Higher per capita healthcare expenditures and rising R&D funding to develop new techniques in spinal care are some of the major factors supporting the growth of the market in the region.
The pedicle screw systems market in the European region accounts for the second-largest market, globally. Factors such as the financial support from the government for research and development activities, the increasing geriatric population and the demand for pedicle screw systems in the treatment procedures of spinal disorders in the region drive the market growth. 
The Asia Pacific pedicle screw systems market is emerging as a profitable market, globally. Rising cases of obesity disorders, increasing healthcare expenditure, increasing government funding, and the presence of a large number of patient population, along with the growing awareness about novel spine treatment techniques in the region are some of the key driving forces behind the growth of the regional market.
Moreover, factors such as the rising number of orthopedic surgeries, rising investments in healthcare and expansions by market players, impact the market growth in the region, positively.


Global Pedicle Screw Systems Market - Competitive Analysis
Highly competitive, the pedicle screw systems market appears to be widely expanded and fragmented characterized by several small and large-scale players. To gain a competitive edge and to sustain their position in the market, these players incorporate various strategic initiatives such as partnership, acquisition, collaboration, expansion, and product launch.
The structure of the market is changing due to the acquisition of local manufactures by multinational companies. Because of the increasing competition in the market, multination companies are using the strategy of acquisition, which increases the profit of the company while significantly reducing the competition.
Industry News
March 06, 2019 --–– SpineGuard, S.A. (France), a leading global company developing and marketing the PediGuard probes for the enhancement of spine surgery such as the smart pedicle screw announced the receiving of the patent for its ultrasound mapping of the spine in France and Japan. This, as a result, strengthens the intellectual property portfolio of SpineGuard for 13 patent families.
The new utilization of ultrasound in surgical robotic platforms offers less dependence on X-Ray. France was the first to grant the patent followed by Japan which is 3rd largest spinal device market globally and an important market with manufacturers of ultrasound imaging platforms.
January 15, 2018 – Altus Spine (the US), a leader in the development and innovation of medical devices used in spinal correction surgery, announced the FDA clearance and market introduction of its new Monaco Pedicle Screw System. The novel system is based on a low-profile screw head design, that can stabilize the spine during non-cervical pedicle fixation targeted to correct deformities of the lumbar spine.
About Us:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , , , ,

Monday 19 August 2019

Worldwide Home Healthcare Market will reach 0.15 Billion US$ by the end of 2022, growing at a CAGR of 8.1% during 2019-2022

Home Healthcare – Industry Snippets
Affordable healthcare services are a primary concern in the modern era. Efforts have been undertaken to provide the same and as an after effect of all these initiatives many new markets have emerged. The global market for home healthcare is the best example of this fact. The research report by Market Research Future suggests that throughout the forecast period of 2017-2022, this market will observe expansion at an astonishing pace.




Home healthcare is a special kind of healthcare service that can be delivered to a patient in the convenience of their homes. Common injuries or illnesses can be treated through these services. There does not necessarily have to be a professional around, the medication can be administered by the near and dear ones of the affected. 
At present, money is tighter than ever and every individual out there is looking to save a few bucks. And home healthcare lets people do exactly that which is why it is being speculated that this market will attain unfathomable success in the forthcoming years. The worldwide market for home healthcare is estimated generate a revenue of around 414681.2 million by the end of the projection period. On the other hand the CAGR for the said term will be around 8.1%. 
The rapid development of the technology sector and rise in the geriatric population are two pillars that support the growth graph of this market. Additional factors that further fuel the market’s progression are higher cost of treatment and hospital stays and increased approval from various government regulated bodies. 
The market may have to face certain hindrances like patient safety concerns. As the procedure are carried out at home there may be a possibility of certain risks like medication faults, contraction of nosocomial infections and development of resistant organisms. Efforts are underway to mitigate these issues.

Home Healthcare Market - Competitive Analysis 
Characterized by the presence of several major well-established players, the global Market of Home Healthcare appears to be highly competitive. Players operating in the global Home Healthcare markets are focusing upon optimized situational awareness for customers and ensure their mission success. Well established players increasingly seeking market expansion through various strategic mergers and acquisitions, innovation, increasing investments in research and development of innovative treatments. Strategic partnerships between Key players support the growth and expansion plans of the key players during the forecast period. While collaborating these players ensure to look for a technology partner whose product aligns with their goals to empower caregivers, optimize their time, and enable them to fulfil their inherent desire to make a difference. Some of the Home Health Care companies provide in-home personal, nursing and respite care for elderly and disabled patients including providing housekeeping, meal prep and dietary needs. Well established players strive to provide exceptional support and develop mobile solution with electronic documentation and automated workflows that can support a faster documentation completion while delivering care with the highest professional, ethical, and safety standards to the patients. 

The industry is transforming rapidly with Technology solutions supported by artificial intelligence (AI) and automation are transforming home healthcare completely. Home healthcare companies are keeping with the pace by adapting an increasingly digitalised world to remain competitive.
With the right technology, home healthcare companies are enhancing their efficiency of processes, in turn improving client and caregiver satisfaction while reducing costs


Home Healthcare Global Market - Regional Analysis 
Globally North America is the largest market for home healthcare. In North America, U.S. holds the largest market share of home healthcare market and is expected to reach to astronomical amounts by the end of forecast period (2016 – 2022). 
Globally, Europe is the fastest growing region and expected to grow at a considerable CAGR during the forecast period. Europe is expected to be the second largest market for home healthcare Whereas Asia Pacific is expected to be the fastest growing market for home healthcare.


Home Healthcare Market - Segmentation 
The Home Healthcare Market can be segmented in to 3 key dynamics for the convenience of the report and enhanced understanding; 
Segmentation By Types : Comprises Products, Services, Solutions and other.
Segmentation By Application : Comprises Wound Care, Patient Education, Nutrition Therapy, Monitoring, and other.
Segmentation By Regions : Comprises Geographical regions - North America, Europe, APAC and Rest of the World.

Industry News:
September 2017 - CellTrak Technologies, provider of the industry’s top Care Delivery Management solution and BAYADA Home Health Care, announced the launch of a new partnership. Caregivers in BAYADA’s Assistive Care State Programs practice offices will use CellTrak’s Care Delivery Management solution to efficiently deliver personal care and household support services, electronically verify visits, and document visit data at the point of care—their patients’ homes.
October 2017 – 
Researchers from Kyoto University's Center of Innovation and Panasonic Corporation together have developed a radar-based device that could instantaneously and accurately measure the body's vital signals. The device was actually developed in 2016 and now they've made it even better with the sensor combined a radar with signal analysis algorithms to measure how the body moves as the heart beats. Body movements vary considerably, so the software filters isolate just the heart's minute motions. Measuring respiration and heart rate -- without attaching cumbersome wires to the body -- will greatly benefit modern medicine and home healthcare



Trending Reports
1. Obesity Management Market Size, Status and Forecast 2019-2022
Obesity Management Market report characterize imperative Portion and contenders of the market regarding market estimate, volume, esteem. This report likewise covers every one of the locales and nations of the world, which demonstrates a territorial improvement status, it additionally incorporates Business Profile, Introduction, Revenue and so on.



2.Aromatherapy Market Size, Status and Forecast 2019-2025
Aromatherapy Market report covers the market landscape and its growth prospects over the coming years, the Report also brief deals with the product life cycle, comparing it to the relevant products from across industries that had already been commercialized details the potential for various applications, discussing about recent product innovations and gives an overview on potential regional market.




About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , , ,

Active Pharmaceutical Ingredients Market Cost Analysis and Growth Factor Report 2017 – 2023

Active Pharmaceutical Market Overview
Market Research Future (MRFR) reports that the global active pharmaceutical market is bound to leap upward steadily with a 4.93% CAGR for the forecast period 2018-2023. Emergence of innovative therapeutics along with development of advanced delivery systems will render the market extremely lucrative for opportunities in the forthcoming years. The progressing popularity of personalized medicines also influences the API market landscape. Additionally, reducing overall cost of manufacturing coupled with supply chain consolidation are responsible for the sizeable growth of the market in recent years. Moreover, growing prevalence of chronic diseases and growing incidences of age-related diseases also are factors affecting the growth positively. Furthermore, patent expiration of major drugs that increased generic drug sales along with government initiatives is flourishing the market growth.


Although, stringent government regulatory requirement and decline in global economics may curb the market growth. However, in terms of clinical efficacy and value, active pharmaceuticals ingredients have become an important component in the healthcare sector. This primarily drives the market to higher levels and helps sustain its position globally.
Active Pharmaceutical Market Competitive Analysis
  • Merck & Co.
  • Boehringer Ingelheim GmbH
  • Novartis AG
  • Eli Lilly, Sanof
  • Bayer
  • Pfizer 
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories, GlaxoSmithKline Plc.
and Company and Teva Pharmaceutical Industries Ltd. are some of the prominent players in the global active pharmaceuticals market. 


Active Pharmaceutical Market Segmentation
The market is segmented on the basis of manufacturing process, type of synthesis, API formulation, application, and molecules.
By manufacturing process, the market is segmented into captive manufacturing and contract manufacturing. Captive manufacturing helps keep the profit within the company, saves money along with tax benefits which have pushed many pharmaceutical companies to follow captive type manufacturing, in turn, thrusting the market forward. Benefits associated with contract manufacturing are cost saving by the company outsourcing to other companies, obtaining high-quality products and fast speed of receiving finished products by the other company. These advantages also drive the companies to opt for contract manufacturing, thus leaving a positive impact on the market.
By type of synthesis, the market is segmented into synthetic and biotech. The market is segmented on the basis of formulation, which is generic API and innovative API. The generic formulation segment holds a lot of weight in the market due to their low cost compared to branded drugs.
By application, the market has been segmented into cardiovascular disease, oncology, neurological disorders, orthopedic disorders, respiratory, gastrointestinal disorders, urology, and others. Active ingredients are used to furnish direct effect in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the body, thus are very essential for healthcare domain. These properties are driving the active pharmaceutical market to experience phenomenal growth. The market is also segmented on the basis of molecule which includes small molecule and large molecule.
Active Pharmaceutical Market Regional Analysis
The global active pharmaceutical ingredient market is segmented on the basis of North America, South America, Asia Pacific, Europe, and Africa.
Among all regions, the America region currently governs the substantial market share, and this is expected to continue during the foreseeable future. This is attributable to the vigorous popularity, and sizeable value of the small molecule segment in both Canada and the U.S. Additionally, the pharmaceutical organizations in the USA have developed quickly in comparison with other countries, thus the pharmaceutical industry is among one of the major and most exceptional ventures in the US nations.
The Europe and Asia Pacific regions are also projected to grow steadily in terms of revenue during the forecast period 2018-2023. In this, Europe accounts for the second largest market for active pharmaceutical ingredients trailed by the Asia Pacific region. The European government policy strongly supports the consumption of generic drugs, which is expected to increase the revenue of the generic drugs over the branded drugs in this region.
Within Asia Pacific region, the market growth is influenced by factors such as the amplified level of expense on equipment and infrastructure, expanding initiatives which are motivating investment in APIs from drug makers. Low working costs, contract manufacturing organizations services along with high investments in biological research also benefit the API market favorably.

Hottest Trending Reports

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , ,

Friday 16 August 2019

Tumor Ablation Market 2019 competitive analysis segmentation industry highlights and forecasts till 2023

This report categorizes the Tumor Ablation market data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors Analysis. 
Tumor Ablation Market Highlights:Tumor ablation is a technique of removal of cancer tissue or cells of kidney, liver, bone, and soft tissue with invasive procedure. It is considered as excellent and convenient treatment option over other conventional surgical techniques. Factors that are propelling the growth of the tumor ablation market are surge in geriatric population, increase in prevalence of different types of cancer, rise in adoption of minimally invasive surgical procedures, increasing research and development in healthcare and advancement in technologies. According to the International Federation of Pharmaceutical Manufacturers & Associations, global pharmaceutical industry has spent more than USD 149.8 billion on pharmaceutical Research and development activities.
The cost containment policies by various governments, stringent regulatory environment for product approval, and scarcity of experts are likely to hinder market growth during the forecast period.

Tumor Ablation Market Regional Analysis:The American market is expected to dominate the global Tumor Ablation Market during the forecast period due to the increase in number of cancer cases along with growing geriatric population, adoption of advance technology in healthcare, and favorable reimbursement and regulatory authorities. The European market is expected to be the second-largest due to increased pool of cancer patients and rising healthcare expenditure. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to the increasing geriatric population in countries such as India and China, government initiatives and investment for the development of healthcare sector. The market in the Middle East & Africa is likely to account for the smallest share of the global tumor ablation market.
Tumor Ablation Market Segmentation:The Global Tumor Ablation Market has been segmented on the basis of technology, treatment, application, and end-user.
The technology segment has been segregated into Radiofrequency, Microwave, Irreversible Electroporation, Cryoablation and others.
On the basis of treatment, the market has been classified as surgical, percutaneous and laparoscopic.
The tumor ablation market, by application, has been segmented into Liver cancer, Lung cancer, Breast cancer, Bone cancer, Prostate cancer and others.
End-user segment is divided into hospitals, surgical and ablation centers, and research institute.
Tumor Ablation Market Key Players:Some of the key players in the global tumor ablation market are SonaCare Medical, Medtronic Plc., EDAP TMS, AngioDynamics Inc., Healthtronics Inc., Neuwave Medical, Inc., Boston Scientific Corporation, Biotronik, Galil Medical, Inc, Misonix Inc., and Covidien PL

Table Of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers

Browse Complete Report @ https://www.marketresearchfuture.com/reports/tumor-ablation-market-7139
About Market Research Future:At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312

Posted by at No comments:
Labels: ,
Subscribe to: Posts (Atom)